This inventor holds 6 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent. Top assignees: Dr. Reddy's Laboratories, Incorporated, Tonix Medicines, Inc., Upsher Smith Laboratories, Inc.. Active years: 2018-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2018-2026
Title: Anil N Namboodiripad: Innovator in Pharmaceutical Solutions
Introduction
Anil N Namboodiripad is a notable inventor based in Yardley, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of migraines. With a total of 6 patents to his name, Namboodiripad's work has had a meaningful impact on patient care.
Latest Patents
Among his latest patents is a pharmaceutical composition for treating migraine. This application relates to a method of treating migraine or cluster headache in a human patient. The method comprises administering subcutaneously a composition that includes sumatriptan or its pharmaceutically acceptable salt, in an amount equivalent to 3 mg sumatriptan base. This innovative approach aims to provide effective relief for those suffering from debilitating headaches.
Career Highlights
Namboodiripad has worked with prominent companies in the pharmaceutical industry, including Dr. Reddy's Laboratories and Upsher Smith Laboratories. His experience in these organizations has allowed him to develop and refine his inventions, contributing to advancements in medical treatments.
Collaborations
Some of his notable coworkers include Prabhu Prabhakara and Rajesh Ramesh Patil. Their collaboration has likely fostered an environment of innovation and creativity, leading to the development of effective pharmaceutical solutions.
Conclusion
Anil N Namboodiripad's contributions to the pharmaceutical field, particularly in migraine treatment, highlight his role as an influential inventor. His patents and collaborations reflect a commitment to improving patient outcomes through innovative solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile